![]() Medically-qualified users will be eligible to receive a prescription for GLP-1 agonists – a class of drugs including Mounjaro, Wegovy and Ozempic that amplify the natural signal between the stomach and the brain indicating fullness – and other anti-obesity medications through the program. The results allow a clinician to create a care plan specific to their health goals. Noom Med users first undergo lab work and a health evaluation by a physician or nurse practitioner. Obesity: Obesity was long considered a personal failing. WeightWatchers: WeightWatchers is adding next-generation weight loss drugs like Wegovy to its program WeightWatchers in March announced that it would also allow members to request weight-loss medications, and Jenny Craig earlier this month confirmed that it was going out of business amid increased competition from weight-loss drugs. ![]() It's the latest sign that the new generation of medication is transforming how the diet industry operates. She said the program's telehealth services and personalized tools should "really help people achieve lasting weight loss and improved health outcomes." “We have always seen weight as a proxy for taking care of other chronic conditions,” said Linda Anegawa, Noom’s chief of medicine and a physician board certified in obesity medicine and internal medicine. The company recently announced the launch of Noom Med, a new program meant to help certain members lose weight with the help of anti-obesity medications like Wegovy. Now, it's going a step further by launching a program that can prescribe a new generation of weight-loss drugs that have gained in popularity. Startup Noom says it helps members lose weight by tracking their diet and promoting healthy habits.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |